Carl Anthony Evans - 21 Sep 2023 Form 4/A - Amendment Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role: Director
Signature: /s/ Christopher Downs, Attorney-in-fact
Issuer symbol: CNSP
Transactions as of: 21 Sep 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 12 Oct 2023, 18:01:15 UTC
Date Of Original Report: 25 Sep 2023
Previous filing: 09 Mar 2022
Next filing: 06 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNSP	Option to purchase common stock	Award		+39,475	+663%		45,428	21 Sep 2023	Common Stock	39,475	$1.09	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
F2	The stock options were issued in connection with the reporting person's Board of Director services to the Company.

Remarks:

This amendment is being filed solely to correct the number of shares of common stock underlying the reported option, and total number of derivative securities owned following the reported transaction.